News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AEterna Zentaris (AEZS) to Present at BioContact in Québec City


9/26/2012 9:51:41 AM

QUÉBEC CITY, Sept. 26, 2012 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that its Senior Vice President and CFO, Dennis Turpin, CPA CA, will be presenting a corporate overview at BioContact on Wednesday, October 3, 2012, at 2 pm (Eastern), in the Grande-Allée Room of the Château Laurier Hotel in Québec City, Canada.

About Aeterna Zentaris

Aeterna Zentaris is an oncology and endocrinology drug development company currently investigating treatments for various unmet medical needs. The Company's pipeline encompasses compounds at all stages of development, from drug discovery through to marketed products. For more information please visit www.aezsinc.com.

SOURCE AETERNA ZENTARIS INC.


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES